EyePoint PharmaceuticalsDaniel Malowany2022-01-17T18:15:33+00:00 Project Description Follow-On OfferingCommon Stock. $21,800,000 Co-ManagerFebruary 2020 Related Project Details Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail